This inventor holds 23 USPTO granted patents and 2 published patent applications, primarily in GABA Receptor Ligands. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Sharpe & Dohme Corp.. Active years: 1993-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bundngford, GB (2001)
- Harlow, GB (2003)
- Buntingford, GB (1993 - 2007)
Company Filing History:
21 out of 2,405 
1 out of 4,770 
1 out of 36 Years Active: 1993-2007
Areas of Expertise:
Title: The Innovative Mind of Kevin William Moore
Introduction
Kevin William Moore is a distinguished inventor based in Buntingford, GB, known for his significant contributions to the field of pharmaceuticals and neuroscience. With an impressive portfolio of 23 patents, he has developed innovative compounds that target GABA receptors, which play a crucial role in the central nervous system.
Latest Patents
Among Kevin's latest patents are two notable classes of derivatives:
1. **Imidazo-pyridine derivatives as ligands for GABA receptors**: This patent describes a class of 8-fluoro-3-phenylimidazo[1,2-α]pyridine derivatives. These compounds are selectively designed to interact with GABA receptors, particularly the α2, α3, and α5 subunits. They hold promise in treating and preventing conditions such as anxiety, convulsions, and cognitive disorders.
2. **Imidazo-pyrimidine derivatives as ligands for GABA receptors**: This patent focuses on imidazo[1,2-α]pyrimidine derivatives, which are substituted at the 3-position by a heteroaromatic ring. These derivatives exhibit a strong affinity for GABA receptors and offer therapeutic benefits for central nervous system conditions, including anxiety and cognitive disorders.
Career Highlights
Kevin has made substantial strides in his career, having worked for reputable companies such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His innovative work in drug development has positioned him as a leader in the pharmaceutical industry.
Collaborations
Throughout his career, Kevin has collaborated with notable colleagues, including William Robert Carling and Leslie Joseph Street. These partnerships have fostered a dynamic exchange of ideas, further enhancing the quality and impact of his inventions.
Conclusion
Kevin William Moore represents the essence of innovation in the field of neuroscience and pharmaceuticals. His contributions through numerous patents and collaborations reflect his commitment to advancing the treatment of central nervous system disorders. With a track record of impactful inventions, he continues to inspire the future of medical research and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile